In 2012 was created Anaxago, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Paris. The venture was found in Europe in France.
This organization was formed by Caroline Lamaud, Franu00e7ois Carbone, Joachim Dupont.
The top activity for fund was in 2017. Speaking about the real fund results, this Corporate Investor is 4 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 1 - 5 millions dollars.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Anaxago, startups are often financed by AGORANOV, CapDecisif, The Family. The meaningful sponsors for the fund in investment in the same round are Petit Poucet, WaterStart Capital, The Family. In the next rounds fund is usually obtained by Wilco, NewAlpha Asset Management, Kima Ventures.
Among the most popular portfolio startups of the fund, we may highlight MeilleureCopro, Novolyze, Algama. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Software, Pharmaceutical.
| Fund Name | Location |
| Beijing Guoyin Xiangyu Touzi Zhongxin | Beijing, Beijing, China |
| Blue Ant Investments | California, United States, Yorba Linda |
| Capital Indigo | Distrito Federal, Mexico, Mexico City |
| ENGEO | California, San Ramon, United States |
| Grab Ventures | Central, Central Region, Singapore |
| igniteXL Ventures | California, Palo Alto, United States |
| Innovation Fund Northeast Ohio | Elyria, Ohio, United States |
| Koonras Technologies | Israel, Tel Aviv, Tel Aviv District |
| Madison Securities | - |
| Missouri Innovation Center | Columbia, Missouri, United States |
| NYU Impact Investment Fund | - |
| Oak Hill Capital Partners | New York, New York, United States |
| Pinpoint Asset Management | China, Hong Kong, Hong Kong Island |
| Pivot Partners | England, London, United Kingdom |
| Ralph Investment Management | China, Jiangsu, Nanjing |
| S-Venture Capital Dortmund | Germany, Saxony-Anhalt, Zehrental |
| SCF Arizona | Arizona, Phoenix, United States |
| Tedlex Capital Partners | - |
| Tokyo Dome Corp. | Japan, Tokyo |
| Wuyuan Technology | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Caravel Pension | $1M | 08 Jun 2022 | Clichy, Ile-de-France, France | ||
Unkle | $11M | 14 Jan 2022 | Paris, Ile-de-France, France | ||
PEP-Therapy | $1M | 19 Jul 2021 | Évry-Courcouronnes, Ile-de-France, France | ||
Xenothera | $21M | 29 Jun 2021 | Nantes, Pays de la Loire, France | ||
OCUS | $24M | 21 Apr 2021 | Paris, Ile-de-France, France | ||
Imageens | $1M | 15 Apr 2021 | Paris, Ile-de-France, France | ||
SweepBright | $2M | 03 Dec 2020 | Antwerp, Antwerp, Belgium | ||
Bulldozair | $4M | 01 Nov 2020 | Paris, Ile-de-France, France | ||
Osivax | $17M | 08 Jul 2020 | France, Auvergne-Rhône-Alpes |
– PEP-Therapy, a biotechnology company based in Paris, raised €3m in Series A funding.
– The funding was led by Anaxago, i&i Prague and BADGE as well as a €1m loan from Bpifrance.
– The company intends to use the funds to finance the Phase I a/b clinical trial of PEP-010, its lead candidate, for the treatment of advanced solid tumors.
– Imageens, a Paris, France-based medical Artificial Intelligence (AI) startup developing software solutions for the analysis of medical images, raised €1.2M in seed financing.
– The round was led by Anaxago, with participation from BADGE (Business Angels des Grandes Ecoles), COALESCENCE, and existing investors.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Caravel Pension | $1M | 08 Jun 2022 | Clichy, Ile-de-France, France | ||
Unkle | $11M | 14 Jan 2022 | Paris, Ile-de-France, France | ||
PEP-Therapy | $1M | 19 Jul 2021 | Évry-Courcouronnes, Ile-de-France, France | ||
Xenothera | $21M | 29 Jun 2021 | Nantes, Pays de la Loire, France | ||
OCUS | $24M | 21 Apr 2021 | Paris, Ile-de-France, France | ||
Imageens | $1M | 15 Apr 2021 | Paris, Ile-de-France, France | ||
SweepBright | $2M | 03 Dec 2020 | Antwerp, Antwerp, Belgium | ||
Bulldozair | $4M | 01 Nov 2020 | Paris, Ile-de-France, France | ||
Osivax | $17M | 08 Jul 2020 | France, Auvergne-Rhône-Alpes |
